Shopping Cart 0
Cart Subtotal
USD 0

Ablynx NV (ABLX)-Medical Equipment-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Ablynx NV (Ablynx) is a clinical-stage biopharmaceutical company focused on the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. Nanobodies are a novel class of antibody-derived therapeutic proteins which possess structural and functional properties of naturally-occurring heavy chain only antibodies. It has advantages of conventional antibodies along with the key features of small molecule drugs. Ablynx product pipeline includes Nanobodies which are being developed to treat serious human diseases including acquired thrombotic thrombocytopenic purpura (aTTp), Psoriasis, bone disorders, cancer and pulmonary diseases. The company has ongoing research collaborations and significant partnerships with key pharmaceutical companies including Merck, Boehringer Ingelheim and Novartis. Ablynx is headquartered in Ghent, Belgium.

Ablynx NV (ABLX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Ablynx NV, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Ablynx NV, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Ablynx NV, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Ablynx NV, Medical Equipment, Deals By Market, 2011 to YTD 2017 8

Ablynx NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Ablynx NV, Medical Equipment, Deal Details 10

Private Equity 10

BVF Partners Acquires Additional 1.74% Stake In Ablynx From Sofinnova 10

Equity Offering 11

Ablynx Raises USD57 Million in Private Placement of Shares 11

Ablynx Completes Private Placement Of Shares For US$1.2 Million Upon Exercise Of Warrants 12

Debt Offering 13

Ablynx Raises USD112 Million in Private Placement of 3.25% Bonds Due 2020 13

Acquisition 14

Sofinnova Divests Its Stake In Ablynx For US$29.4 Million 14

Ablynx NV-Key Competitors 15

Key Employees 16

Locations And Subsidiaries 17

Head Office 17

Recent Developments 18

Financial Announcements 18

Feb 23, 2017: Ablynx Announces 2016 Full Year Results 18

Nov 23, 2016: Ablynx Announces Results For The First Nine Months Of 2016 And A Year-To-Date Business Update 19

Aug 25, 2016: Ablynx Announces 2016 Half-year Results And Year-to-date Business Update 21

May 12, 2016: Ablynx Reports Financial Results For The First Three Months Of 2016 And Provides Business Update Year-To-Date 25

Feb 25, 2016: Ablynx Announces 2015 Full Year Results 27

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

Ablynx NV, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Ablynx NV, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Ablynx NV, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Ablynx NV, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Ablynx NV, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Ablynx NV, Medical Equipment, Deals by Type, 2011 to YTD 2017 6

Ablynx NV, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Ablynx NV, Medical Equipment, Deals by Market, 2011 to YTD 2017 8


List Of Table

List of Tables

Ablynx NV, Medical Equipment, Key Facts, 2016 1

Ablynx NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Ablynx NV, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Ablynx NV, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Ablynx NV, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Ablynx NV, Deals By Market, 2011 to YTD 2017 8

Ablynx NV, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

BVF Partners Acquires Additional 1.74% Stake In Ablynx From Sofinnova 10

Ablynx Raises USD57 Million in Private Placement of Shares 11

Ablynx Completes Private Placement Of Shares For US$1.2 Million Upon Exercise Of Warrants 12

Ablynx Raises USD112 Million in Private Placement of 3.25% Bonds Due 2020 13

Sofinnova Divests Its Stake In Ablynx For US$29.4 Million 14

Ablynx NV, Key Competitors 15

Ablynx NV, Key Employees 16

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com